- Exchange: ASE
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for Mesoblast Ltd (MSB)
| Open: | 6.6000 | Day's Range: | 6.4000 - 6.6200 | Volume: | 332,245 | Bid: | 6.4700 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 6.7000 | 52wk Range: | 6.0900 - 10.0400 | 1-Yr Rtn: | -17.05% | Ask: | 6.4800 |
Key Statistics for MSB
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (06/2012) | - |
| Earnings Per Share (AUD) (ttm) | -0.1684 |
| Est. EPS (AUD) (06/2012) | -0.1620 |
| Est. PEG Ratio | - |
| Market Cap (M AUD) | 1,840.57 |
| Shares Outstanding (M) | 284.48 |
| Enterprise Value (M AUD) (ttm) | 1,599.73 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 3.6578 |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/24/2012 |
More MSB Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for MSB
- Operating
- Investing
- Financing (M/AUD)
Company Profile & Key Executives for MSB
Mesoblast Ltd., is a biotechnology company. The Company develops treatments for orthopaedic conditions, including the commercialisation of adult stem cells to regenerate, repair bone. and cartilage.
| Brian JamiesonChairman | Donal P O'DwyerDeputy Chairman |
| Silviu ItescuCEO/Executive Director | Jenni PilcherCFO/Secretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page